Lv3
400 积分 2026-05-13 加入
Hallmarks of cancer—Then and now, and beyond
4天前
已完结
Targeting the poliovirus receptor to activate T cells and induce myeloid-derived suppressor cells to differentiate to pro-inflammatory macrophages via the IFN-γ-p-STAT1-IRF8 axis in cancer therapy
18天前
已完结
Biliary Tract Cancers
1个月前
已完结
Integrative Molecular Insights Into Epidemiological, Genetic, and Metabolic Risk Factors of Gallbladder Cancer: Implications for Biomarkers, Therapeutic Targeting, and Future Perspectives
1个月前
已完结
Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer: A new era begins
1个月前
已完结
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
Multi‐Omics Integrated Analysis of the Protective Effect of Tertiary Lymphoid Structures and Associated Key Regulatory Genes in Human Gallbladder Cancer
1个月前
已完结
A guide to thymic selection of T cells
1个月前
已完结
Targeting the RAS upstream and downstream signaling pathway for cancer treatment
1个月前
已完结
Targeting PI3K/AKT/mTOR signaling to overcome drug resistance in cancer
1个月前
已完结
皖公网安备34019202002308
